FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:STK38L-ALB (FusionGDB2 ID:86962)

Fusion Gene Summary for STK38L-ALB

check button Fusion gene summary
Fusion gene informationFusion gene name: STK38L-ALB
Fusion gene ID: 86962
HgeneTgene
Gene symbol

STK38L

ALB

Gene ID

23012

213

Gene nameserine/threonine kinase 38 likealbumin
SynonymsNDR2HSA|PRO0883|PRO0903|PRO1341
Cytomap

12p11.23

4q13.3

Type of geneprotein-codingprotein-coding
Descriptionserine/threonine-protein kinase 38-likeNDR2 protein kinasenuclear Dbf2-related 2nuclear Dbf2-related kinase 2serum albumin
Modification date2020031320200329
UniProtAcc.

P02768

Ensembl transtripts involved in fusion geneENST00000389032, ENST00000539577, 
ENST00000295897, ENST00000415165, 
ENST00000503124, ENST00000509063, 
ENST00000401494, ENST00000505649, 
Fusion gene scores* DoF score9 X 5 X 5=22549 X 62 X 5=15190
# samples 964
** MAII scorelog2(9/225*10)=-1.32192809488736
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(64/15190*10)=-4.56890615450208
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: STK38L [Title/Abstract] AND ALB [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointSTK38L(27476263)-ALB(74279302), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneSTK38L

GO:0006468

protein phosphorylation

15037617|15067004

HgeneSTK38L

GO:0035556

intracellular signal transduction

15067004

TgeneALB

GO:0009267

cellular response to starvation

16245148

TgeneALB

GO:0043066

negative regulation of apoptotic process

16153637

TgeneALB

GO:0051659

maintenance of mitochondrion location

16153637


check buttonFusion gene breakpoints across STK38L (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across ALB (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChiTaRS5.0N/AAI114516STK38Lchr12

27476263

+ALBchr4

74279302

+


Top

Fusion Gene ORF analysis for STK38L-ALB

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
3UTR-3CDSENST00000389032ENST00000295897STK38Lchr12

27476263

+ALBchr4

74279302

+
3UTR-3CDSENST00000389032ENST00000415165STK38Lchr12

27476263

+ALBchr4

74279302

+
3UTR-3CDSENST00000389032ENST00000503124STK38Lchr12

27476263

+ALBchr4

74279302

+
3UTR-3CDSENST00000389032ENST00000509063STK38Lchr12

27476263

+ALBchr4

74279302

+
3UTR-3CDSENST00000389032ENST00000401494STK38Lchr12

27476263

+ALBchr4

74279302

+
3UTR-3UTRENST00000389032ENST00000505649STK38Lchr12

27476263

+ALBchr4

74279302

+
intron-3CDSENST00000539577ENST00000295897STK38Lchr12

27476263

+ALBchr4

74279302

+
intron-3CDSENST00000539577ENST00000415165STK38Lchr12

27476263

+ALBchr4

74279302

+
intron-3CDSENST00000539577ENST00000503124STK38Lchr12

27476263

+ALBchr4

74279302

+
intron-3CDSENST00000539577ENST00000509063STK38Lchr12

27476263

+ALBchr4

74279302

+
intron-3CDSENST00000539577ENST00000401494STK38Lchr12

27476263

+ALBchr4

74279302

+
intron-3UTRENST00000539577ENST00000505649STK38Lchr12

27476263

+ALBchr4

74279302

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for STK38L-ALB


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for STK38L-ALB


check button Go to

FGviewer for the breakpoints of :-:

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
.ALB

P02768

FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.FUNCTION: Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc (PubMed:19021548). Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity). Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity). Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli (PubMed:6234017). Does not prevent iron uptake by the bacterial siderophore aerobactin (PubMed:6234017). {ECO:0000250|UniProtKB:P02769, ECO:0000269|PubMed:19021548, ECO:0000269|PubMed:6234017, ECO:0000305|PubMed:1630489}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for STK38L-ALB


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for STK38L-ALB


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for STK38L-ALB


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB00493CefotaximeSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB11359GuaiacolSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB13967Patent BlueBinderSmall moleculeApproved
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB03255PhenolSmall moleculeApproved|Experimental
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00276AmsacrineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB00545PyridostigmineSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB06713NorelgestrominSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational
TgeneALBP02768DB12965SilverBinderSmall moleculeApproved|Investigational

Top

Related Diseases for STK38L-ALB


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneALBC0033687Proteinuria9CTD_human
TgeneALBC0017658Glomerulonephritis8CTD_human
TgeneALBC0022658Kidney Diseases8CTD_human
TgeneALBC1704377Bright Disease8CTD_human
TgeneALBC0017665Membranous glomerulonephritis6CTD_human
TgeneALBC0027697Nephritis6CTD_human
TgeneALBC0086445Idiopathic Membranous Glomerulonephritis6CTD_human
TgeneALBC0342185Hyperthyroxinemia, Familial Dysalbuminemic6CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneALBC1704378Heymann Nephritis6CTD_human
TgeneALBC0022660Kidney Failure, Acute4CTD_human
TgeneALBC0027707Nephritis, Interstitial4CTD_human
TgeneALBC0038454Cerebrovascular accident4CTD_human
TgeneALBC0041349Nephritis, Tubulointerstitial4CTD_human
TgeneALBC0751956Acute Cerebrovascular Accidents4CTD_human
TgeneALBC1565662Acute Kidney Insufficiency4CTD_human
TgeneALBC2609414Acute kidney injury4CTD_human
TgeneALBC0023893Liver Cirrhosis, Experimental3CTD_human
TgeneALBC0025290Aseptic Meningitis3CTD_human
TgeneALBC0013221Drug toxicity2CTD_human
TgeneALBC0014544Epilepsy2CTD_human
TgeneALBC0019193Hepatitis, Toxic2CTD_human
TgeneALBC0020649Hypotension2CTD_human
TgeneALBC0023890Liver Cirrhosis2CTD_human
TgeneALBC0027726Nephrotic Syndrome2CTD_human
TgeneALBC0036830Serum Sickness2CTD_human
TgeneALBC0041755Adverse reaction to drug2CTD_human
TgeneALBC0086237Epilepsy, Cryptogenic2CTD_human
TgeneALBC0162557Liver Failure, Acute2CTD_human
TgeneALBC0236018Aura2CTD_human
TgeneALBC0239946Fibrosis, Liver2CTD_human
TgeneALBC0751111Awakening Epilepsy2CTD_human
TgeneALBC0860207Drug-Induced Liver Disease2CTD_human
TgeneALBC0878666Analbuminemia2ORPHANET
TgeneALBC1262760Hepatitis, Drug-Induced2CTD_human
TgeneALBC3658290Drug-Induced Acute Liver Injury2CTD_human
TgeneALBC4277682Chemical and Drug Induced Liver Injury2CTD_human
TgeneALBC4279912Chemically-Induced Liver Toxicity2CTD_human
TgeneALBC0002994Angioedema1CTD_human
TgeneALBC0003460Anuria1CTD_human
TgeneALBC0003865Arthritis, Adjuvant-Induced1CTD_human
TgeneALBC0004509Azoospermia1CTD_human
TgeneALBC0005398Cholestasis, Extrahepatic1CTD_human
TgeneALBC0006111Brain Diseases1CTD_human
TgeneALBC0007222Cardiovascular Diseases1CTD_human
TgeneALBC0007786Brain Ischemia1CTD_human
TgeneALBC0008312Primary biliary cirrhosis1CTD_human
TgeneALBC0011573Endogenous depression1CTD_human
TgeneALBC0011581Depressive disorder1CTD_human
TgeneALBC0011875Diabetic Angiopathies1CTD_human
TgeneALBC0011881Diabetic Nephropathy1CTD_human
TgeneALBC0013502Echinococcosis1CTD_human
TgeneALBC0014518Toxic Epidermal Necrolysis1CTD_human
TgeneALBC0016059Fibrosis1CTD_human
TgeneALBC0017662Glomerulonephritis, Membranoproliferative1CTD_human
TgeneALBC0017667Nodular glomerulosclerosis1CTD_human
TgeneALBC0018799Heart Diseases1CTD_human
TgeneALBC0018801Heart failure1CTD_human
TgeneALBC0018802Congestive heart failure1CTD_human
TgeneALBC0019061Hemolytic-Uremic Syndrome1CTD_human
TgeneALBC0019158Hepatitis1CTD_human
TgeneALBC0019209Hepatomegaly1CTD_human
TgeneALBC0019693HIV Infections1CTD_human
TgeneALBC0019699HIV Seropositivity1CTD_human
TgeneALBC0020517Hypersensitivity1CTD_human
TgeneALBC0020522Delayed Hypersensitivity1CTD_human
TgeneALBC0020538Hypertensive disease1CTD_human
TgeneALBC0022548Keloid1CTD_human
TgeneALBC0022661Kidney Failure, Chronic1CTD_human
TgeneALBC0023212Left-Sided Heart Failure1CTD_human
TgeneALBC0023892Biliary cirrhosis1CTD_human
TgeneALBC0024623Malignant neoplasm of stomach1CTD_human
TgeneALBC0025193Melancholia1CTD_human
TgeneALBC0025945Microangiopathy, Diabetic1CTD_human
TgeneALBC0026848Myopathy1CTD_human
TgeneALBC0027055Myocardial Reperfusion Injury1CTD_human
TgeneALBC0027720Nephrosis1CTD_human
TgeneALBC0028797Occupational Diseases1CTD_human
TgeneALBC0030193Pain1CTD_human
TgeneALBC0030286Pancreatic Diseases1CTD_human
TgeneALBC0030305Pancreatitis1CTD_human
TgeneALBC0035222Respiratory Distress Syndrome, Adult1CTD_human
TgeneALBC0035242Respiratory Tract Diseases1CTD_human
TgeneALBC0035457Rhinitis, Allergic, Perennial1CTD_human
TgeneALBC0038325Stevens-Johnson Syndrome1CTD_human
TgeneALBC0038356Stomach Neoplasms1CTD_human
TgeneALBC0040034Thrombocytopenia1CTD_human
TgeneALBC0041696Unipolar Depression1CTD_human
TgeneALBC0042109Urticaria1CTD_human
TgeneALBC0042164Uveitis1CTD_human
TgeneALBC0085584Encephalopathies1CTD_human
TgeneALBC0086133Depressive Syndrome1CTD_human
TgeneALBC0152013Adenocarcinoma of lung (disorder)1CTD_human
TgeneALBC0234230Pain, Burning1CTD_human
TgeneALBC0234238Ache1CTD_human
TgeneALBC0234254Radiating pain1CTD_human
TgeneALBC0235527Heart Failure, Right-Sided1CTD_human
TgeneALBC0238065Secondary Biliary Cholangitis1CTD_human
TgeneALBC0239981Hypoalbuminemia1CTD_human
TgeneALBC0268742Membranoproliferative Glomerulonephritis, Type I1CTD_human
TgeneALBC0268743Membranoproliferative Glomerulonephritis, Type II1CTD_human
TgeneALBC0273115Lung Injury1CTD_human
TgeneALBC0282126Depression, Neurotic1CTD_human
TgeneALBC0458257Pain, Splitting1CTD_human
TgeneALBC0458259Pain, Crushing1CTD_human
TgeneALBC0751407Pain, Migratory1CTD_human
TgeneALBC0751408Suffering, Physical1CTD_human
TgeneALBC0917798Cerebral Ischemia1CTD_human
TgeneALBC0971858Arthritis, Collagen-Induced1CTD_human
TgeneALBC0993582Arthritis, Experimental1CTD_human
TgeneALBC1274933Drug-Induced Stevens Johnson Syndrome1CTD_human
TgeneALBC1306571Hepatic Insufficiency1CTD_human
TgeneALBC1527304Allergic Reaction1CTD_human
TgeneALBC1623038Cirrhosis1CTD_human
TgeneALBC1708349Hereditary Diffuse Gastric Cancer1CTD_human
TgeneALBC1720821Membranoproliferative Glomerulonephritis, Type III1CTD_human
TgeneALBC1959583Myocardial Failure1CTD_human
TgeneALBC1961112Heart Decompensation1CTD_human
TgeneALBC2350344Chronic Lung Injury1CTD_human
TgeneALBC3658301Mycoplasma-Induced Stevens-Johnson Syndrome1CTD_human
TgeneALBC3658302Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum1CTD_human
TgeneALBC4505456HIV Coinfection1CTD_human
TgeneALBC4551595Biliary Cirrhosis, Primary, 11CTD_human
TgeneALBC4553297Cystic Echinocccosis1CTD_human